Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-10 | New | $5,270,000 | $5,270,000 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Samuel Myllykangas | Director, Executive |
| Jussi Paananen | Director, Executive |
| David Proctor | Director |